Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA international commissioner appointed

Executive Summary

FDA appoints Lou Valdez as associate commissioner for international programs, a role in which she will lead implementation of FDA's international programs. Valdez previously served as deputy director in the HHS Office of Global Health Affairs, where she led the development of U.S. government policy positions. She enters her new role at a time of significant expansion of the agency's international presence; in addition to the recent opening of offices in China, FDA announced the opening of its first office in India Jan. 15 (1PharmAsia News, Jan. 15, 2009)

You may also be interested in...



U.S. FDA Opens First Office In India, A “Portal” To The Agency

U.S. Health and Human Services Secretary Michael Leavitt and U.S. FDA Commissioner Andrew von Eschenbach announced Jan. 15 the opening of FDA's first office in India, which will be in New Delhi. An FDA official told PharmAsia News the agency is awaiting permission from India to open a second office in Mumbai

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.

CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings

FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS050559

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel